UqbaKhanMD

PubMed

• 2 citations
  Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
  Dharmapuri, S., Özbek, U., Jethra, H., Jun, T., Marron, T., Saeed, A., Huang, Y., Muzaffar, M., Pinter, M., Balcar, L., Fulgenzi, C., Amara, S., Weinmann, A., Personen...> ;World Journal of Gastrointestinal Oncology. 2023 Nov 15
• 3 citations
  Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.
  Pashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D Jafari, Heather Yeo, Lea Lowenfeld, Uqba Khan, Alana T H Nguyen, Despina Siolas, Brandon Swed, Jini Hyun, Sahrish Kha...> ;Oncogene. 2023 Oct 1
• 1 citations
  Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers.
  Frederic Karim, Adina Amin, Marie Liu, Nivetha Vishnuvardhan, Saif Amin, Raffey Shabbir, Brandon Swed, Uqba Khan> ;Cancers. 2023 Aug 14
• 31 citations
  Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
  Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, Thierry Alcindor, Angela N Bartley, Aubrey Belk Malowany, Nishin A Bhadkamkar, Dana C Deighton, Yelena Janjigian...> ;Journal of Clinical Oncology. 2023 Mar 1
• 6 citations
  Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
  Thomas Talbot, Antonio D'Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hil...> ;Liver International. 2023 Mar 1
• Fatalistic cancer beliefs and self-reported cancer screening behaviors among diverse urban residents.
  Laura C Pinheiro, Orysya Soroka, Dominic T Razon, Francesse Antoine, Julia Rothman, Margaux J Kanis, Uqba Khan, Rulla M Tamimi, David Nanus, Erica Phillips> ;Journal of Behavioral Medicine. 2022 Dec 1
• 5 citations
  A Review of Current and Emerging Therapies for Advanced Hepatocellular Carcinoma.
  Angelica Singh, Sofia Zahid, Ilya Noginskiy, Timothy Pak, Soeb Usta, Marina Barsoum, Uqba Khan> ;Current Oncology. 2022 Sep 8
• 5 citations
  Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
  Rohini Sharma, Anjana Pillai, Thomas Urban Marron, Petros Fessas, Anwaar Saeed, Tomi Jun, Sirish Dharmapuri, David Szafron, Abdul Rafeh Naqash, Anuhya Gampa, Yinghong ...> ;Hepatology Communications. 2022 Jul 1
• 20 citations
  Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity sc...
  Brett Marinelli, Edward Kim, Antonio D'Alessio, Mario Cedillo, Ishan Sinha, Neha Debnath, Masatoshi Kudo, Naoshi Nishida, Anwaar Saeed, Hannah Hildebrand, Ahmed O Kase...> ;Journal for Immunotherapy of Cancer. 2022 Jun 1
• 36 citations
  The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
  Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Anwaar Saeed, Hannah ...> ;Cancers. 2021 Dec 31
• 39 citations
  Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with vali...
  David J. Pinato, Thomas U. Marron, Pallavi S. Mishra-Kalyani, Yutao Gong, Guo Wei, David Szafron, Elad Sharon, Anwaar Saeed, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh N...> ;European Journal of Cancer. 2021 Sep 8
• 15 citations
  Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
  Tomi Jun, Umut Ozbek, Sirish Dharmapuri, Camille Hardy-Abeloos, Huili Zhu, Jung-Yi Lin, Nicola Personeni, Tiziana Pressiani, Naoshi Nishida, Pei Chang Lee, Chieh Ju Le...> ;Therapeutic Advances in Medical Oncology. 2021 Apr 28
• 15 citations
  Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment.
  Uqba Khan, Kaylee Ho, Eun Kyeong Hwang, Cristian Peña, Julianna Brouwer, Katherine Hoffman, Doron Betel, Gregory F. Sonnenberg, Bishoy Faltas, Ashish Saxena, Kaitlin E...> ;American Journal of Clinical Oncology. 2021 Apr 6
• 32 citations
  Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma
  Petros Fessas, Muntaha Naeem, Matthias Pinter, Thomas U. Marron, David Szafron, Lorenz Balcar, Anwaar Saeed, Tomi Jun, Sirish Dharmapuri, Anuhya Gampa, Yinghong Wang, ...> ;Liver Cancer. 2021 Jan 1
• 19 citations
  Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.
  David J. Pinato, Ahmed Kaseb, Yinghong Wang, Anwaar Saeed, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Uqba Kha...> ;Journal for Immunotherapy of Cancer. 2020 Oct 1
• 14 citations
  Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies.
  Anita Mazloom, Nima Ghalehsari, Victor Gazivoda, Neil Nimkar, Sonal Paul, Peter Gregos, Janice Rateshwar, Uqba Khan> ;Journal of Clinical Medicine. 2020 Aug 6
• 41 citations
  Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
  Petros Fessas, Ahmed Kaseb, Yinghong Wang, Anwaar Saeed, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Uqba Khan,...> ;Journal for Immunotherapy of Cancer. 2020 Aug 1
• 42 citations
  Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.
  David J. Pinato, Takahiro Kaneko, Anwaar Saeed, Tiziana Pressiani, Ahmed Kaseb, Yinghong Wang, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish ...> ;Cancers. 2020 Jul 10
• 20 citations
  Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer.
  Uqba Khan, Manish A. Shah> ;Expert Opinion on Biological Therapy. 2019 Aug 27
• 10 citations
  Optimizing Therapies in the Perioperative Management of Gastric Cancer
  Uqba Khan, Manish A. Shah> ;Current Treatment Options in Oncology. 2019 May 29
• 15 citations
  Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
  Daniel W. Lin, Uqba Khan, Thorsten Oliver Goetze, Natalie Reizine, Karyn A. Goodman, Manish A. Shah, Daniel V.T. Catenacci, Salah-Eddin Al-Batran, James Posey> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2019 May 17
• 2 citations
  Prognostic Utility of Tumor-Infiltrating Lymphocytes in Noncolorectal Gastrointestinal Malignancies.
  Ameer Hamza, Uqba Khan, Muhammad Khurram, Renny Abraham, Paul Mazzara, Tarik Hadid, Zyad Kafri> ;International Journal of Surgical Pathology. 2019 May 1
• 8 citations
  Role of "Second Look" Lymph Node Search in Harvesting Optimal Number of Lymph Nodes for Staging of Colorectal Carcinoma.
  Ameer Hamza, Ramen Sakhi, Sidrah Khawar, Ahmed Alrajjal, Jacob Edens, Muhammad Siddique Khurram, Uqba Khan, Susanna Szpunar, Paul Mazzara> ;Gastroenterology Research and Practice. 2018 Apr 2
• Acute myeloid leukemia with translocation (1;21).
  Ameer Hamza, Uqba Khan, Sidrah Khawar, Daniel Snower> ;Molecular Biology Reports. 2018 Mar 22
• 21 citations
  Appendiceal Duplication: A Comprehensive Review of Published Cases and Clinical Recommendations
  H. Nageswaran, Uqba Khan, F. Hill, A. Maw> ;World Journal of Surgery. 2018 Feb 1
• Join now to see all

Lectures

• Phase II study of a telomerase-specific oncolytic adenovirus (OBP-301, Telomelysin) in combination with pembrolizumab in gastric and gastroesophageal junction adenocar... 
  2019 ASCO Annual Meeting - 6/1/2019